Clinical Partnerships Asia Pacific Welcome

Welcome to CROs Asia

The future of the pharmaceutical industry is a global one. Conducting clinical research in Asia is no longer a strategy to improve timelines and cost savings, it is the only way to maintain a globally competitive pipeline.

Approval and global market share aside, many argue that site and investigator quality is unmatched in some Asian countries as is the availability of a naïve patient population. There is no better time than the present to join the thousands who have participated in Partnerships in Clinical Trials to hone your partnerships skills and improve clinical operations.

No other event focuses solely on the business of clinical research and outsourcing. Senior-level executives based in the US and EU know that there is no substitute for the personal interactions required to foster the understanding of the infrastructure, capabilities and opportunities – as well as the risks and myths about conducting studies in the region. Experience Partnerships to get answers to your most pressing questions including:

How does the current APAC environment compare to the US/EU CRO industry 10 years ago?
What can be learned from the history of CRO and pharma partnership development outside of Asia?
What are the advantages, disadvantages and realities of conducting trials in China, Japan, India, and emerging markets like Thailand, Vietnam and Sri Lanka
How will decades of experience in the US and Europe inform and accelerate the evolution of strategic outsourcing partnerships in Asia?
What is the best way to build a local network to improve communication with local regulatory authorities?
How is the changing R&D model going to impact the CRO market?
What are the regional trends for trial placement and cost per subject?

Overcome the challenge of getting patient samples out of the county for testing
and storage

The future of the pharmaceutical industry is a global one. For 20 years,
Partnerships in Clinical Trials has led the pharmaceutical industry in examining critical issues and decisions around different outsourcing models and best practices in successfully managing the many facets of clinical trials. After a successful debut in the Asia Pacific region in 2009, we are delighted to return to Singapore this October with an even more comprehensive program and speaker lineup.


Mark Bach, PhD, VP, Head of Japan R&D, JANSSEN PHARMACEUTICALS KK	Fidela Moreno, MD, Vice President Global Development, Clinical Site Management & Monitoring, ALLERGAN	Ann Wang, Vice President, Clinical Operations and Data Management, HUMAN GENOME SCIENCES	Larry Fiori, Associate Director, Clinical Trial Outsourcing & Compliance, Compliance and Quality Management, BOEHRINGER INGELHEIM